1. Home/
  2. Compounds/
  3. erlotinib:PLX-4032 (2:1 mol/mol)

erlotinib:PLX-4032 (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2erlotinib:PLX-4032 (2:1 mol/mol)
PharmacoGx erlotinib:PLX-4032 (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to erlotinib:PLX-4032 (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SERPINB11 CTRPv2 pan-cancer AAC 0.088 0.02
mRNA SLC35E2B CTRPv2 pan-cancer AAC -0.096 0.02
mRNA PAF1 CTRPv2 pan-cancer AAC -0.093 0.02
mRNA ZNF496 CTRPv2 pan-cancer AAC -0.093 0.02
mRNA SAMD1 CTRPv2 pan-cancer AAC -0.098 0.02
mRNA MRPL34 CTRPv2 pan-cancer AAC -0.096 0.02
mRNA NOA1 CTRPv2 pan-cancer AAC -0.1 0.02
mRNA ANKRD34A CTRPv2 pan-cancer AAC -0.091 0.02
mRNA LYST CTRPv2 pan-cancer AAC 0.098 0.02
mRNA GAGE12J CTRPv2 pan-cancer AAC -0.088 0.02
Download CSV